Literature DB >> 11807981

Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression.

Iwona Wlodarska1, Nadine Martin-Garcia, Ruth Achten, Chris De Wolf-Peeters, Patrick Pauwels, Micheline Tulliez, Antoine de Mascarel, Josette Brière, Martine Patey, Anne Hagemeijer, Philippe Gaulard.   

Abstract

Hepatosplenic gamma delta T-cell lymphoma (HS gamma delta TCL) is a rare and aggressive subtype of peripheral T-cell lymphoma that has been associated cytogenetically with the isochromosome 7q [i(7)(q10)]. The incidence of this aberration and its relevance to pathogenesis of HS gamma delta TCL is still unknown. We investigated the status of chromosome 7 in 12 HSTCL cases, including nine with a typical gamma delta phenotype, one with a so-called T-cell receptor (TCR)-silent phenotype, and two with the variant alpha beta phenotype. We analyzed available fresh and archival material using a dual-color interphase fluorescence in situ hybridization (FISH) approach with 7p and 7q probes. A significant population of cells with predominance of 7q signals was detected in 10 cases (eight gamma delta, one alpha beta, and one TCR silent), and two lymphomas did not show clonal 7p/7q signal imbalances. In four of 10 cases with chromosome 7 aberrations, a hybridization pattern indicative of the presence of one chromosome 7 and one i(7)(q10) was found. In four other cases, the configuration of signals (2 x 7p/3 x 7q) suggested the presence of the i(7)(q10) and additional structural aberrations involving the second chromosome 7. In two cases, including one alpha beta phenotypic variant, a variety of FISH patterns equivalent to two to five copies of i(7)(q10) or numerical and structural aberrations of second chromosome 7 has been detected. These findings support cytogenetic data pointing to a characteristic association of i(7)(q10) with HSTCL, irrespective of the immunophenotype of malignant cells. An increased number of 7q signals was found in three cases with cytologic features of progression, indicating a tendency of HSTCL to multiply the i(7)(q10) chromosome during evolution. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11807981     DOI: 10.1002/gcc.10021

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  14 in total

1.  Hepatosplenic gammadelta T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration.

Authors:  Julia Tamaska; Emma Adam; Andras Kozma; Laszlo Gopcsa; Hajnalka Andrikovics; Attila Tordai; Gabriella Halm; Laszlo Bereczki; Eniko Bagdi; Laszlo Krenacs
Journal:  Virchows Arch       Date:  2006-08-29       Impact factor: 4.064

Review 2.  Update on the World Health Organization classification of peripheral T-cell lymphomas.

Authors:  Hilary M O'Leary; Kerry J Savage
Journal:  Curr Hematol Malig Rep       Date:  2009-10       Impact factor: 3.952

3.  The Genetic Basis of Hepatosplenic T-cell Lymphoma.

Authors:  Matthew McKinney; Andrea B Moffitt; Philippe Gaulard; Marion Travert; Laurence De Leval; Alina Nicolae; Mark Raffeld; Elaine S Jaffe; Stefania Pittaluga; Liqiang Xi; Tayla Heavican; Javeed Iqbal; Karim Belhadj; Marie Helene Delfau-Larue; Virginie Fataccioli; Magdalena B Czader; Izidore S Lossos; Jennifer R Chapman-Fredricks; Kristy L Richards; Yuri Fedoriw; Sarah L Ondrejka; Eric D Hsi; Lawrence Low; Dennis Weisenburger; Wing C Chan; Neha Mehta-Shah; Steven Horwitz; Leon Bernal-Mizrachi; Christopher R Flowers; Anne W Beaven; Mayur Parihar; Lucile Baseggio; Marie Parrens; Anne Moreau; Pierre Sujobert; Monika Pilichowska; Andrew M Evens; Amy Chadburn; Rex K H Au-Yeung; Gopesh Srivastava; William W L Choi; John R Goodlad; Igor Aurer; Sandra Basic-Kinda; Randy D Gascoyne; Nicholas S Davis; Guojie Li; Jenny Zhang; Deepthi Rajagopalan; Anupama Reddy; Cassandra Love; Shawn Levy; Yuan Zhuang; Jyotishka Datta; David B Dunson; Sandeep S Davé
Journal:  Cancer Discov       Date:  2017-01-25       Impact factor: 39.397

Review 4.  Peripheral T-cell lymphoma.

Authors:  Wing Y Au; Raymond Liang
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

5.  Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.

Authors:  G S Falchook; F Vega; N H Dang; F Samaniego; M A Rodriguez; R E Champlin; C Hosing; S Verstovsek; B Pro
Journal:  Ann Oncol       Date:  2009-02-23       Impact factor: 32.976

Review 6.  Gamma-delta T-cell lymphomas.

Authors:  Claudio Tripodo; Emilio Iannitto; Ada Maria Florena; Carlo Ennio Pucillo; Pier Paolo Piccaluga; Vito Franco; Stefano Aldo Pileri
Journal:  Nat Rev Clin Oncol       Date:  2009-11-10       Impact factor: 66.675

Review 7.  Hepatosplenic T-cell lymphoma: a rare but challenging entity.

Authors:  Barbara Pro; Pamela Allen; Amir Behdad
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

8.  Hepatosplenic T-Cell Lymphoma: A Population-Based Study Assessing Incidence and Association With Immune-Mediated Disease.

Authors:  Michael Montgomery; Marije M van Santen; Bart J Biemond; Robert H Diamond; Steven T Pals
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-03

9.  Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.

Authors:  Martin H Voss; Matthew A Lunning; Jocelyn C Maragulia; Esperanza B Papadopoulos; Jenna Goldberg; Andrew D Zelenetz; Steven M Horwitz
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-10-27

10.  Hepatosplenic T-cell lymphoma in a young immunocompetent man.

Authors:  Maja Petrova; Manuel Mendes Gomes; Jose Pedro Nascimento Carda; José Pereira de Moura
Journal:  BMJ Case Rep       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.